WCN26-7672 PATIENT PERSPECTIVES ON PHARMACOLOGICAL TREATMENTS FOR GLOMERULONEPHRITIS: PRIORITIZING DISEASE CONTROL, ORAL TREATMENTS AND SHARED DECISION-MAKING

Read full text Summarise with VIRAT
Authors: Manuel Praga, Fernando Caravaca‐Fontán, Álvaro Madrid Arís, Marta Moreno-Barón, Julieta Nafissi, Marian Vidal-Jorge
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Chronic glomerulonephritis (CGN) significantly impacts patients (pts) on physical, emotional, and economic levels due to its symptoms and prognosis. This collaborative study with the National Federation of Associations for the Fight Against Kidney Diseases (ALCER, according to Spanish spelling), aims to describe the burden of CGN from the pts’ perspective, and to identify and prioritize their preferences regarding pharmacological treatment (tx). Understanding what pts value most can guide tx decisions and enhance the evidence base for shared decision-making in patient-centered care.

Fields of Study & Subjects

Renal Diseases and Glomerulopathies Dialysis and Renal Disease Management Patient-Provider Communication in Healthcare

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
106299–106299
Publication date
25 March 2026
Language
EN